News | May 20, 2023
Abbott India posts Q4FY23 PAT at Rs. 231.42 Cr
The company has reported total income of Rs. 1392.72 crores during the period ended March 31, 2023
The company has reported total income of Rs. 1392.72 crores during the period ended March 31, 2023
PAT rises to Rs 195.76 crore
Prior to joining Eris, Ranganathan was Commercial Director, Women's Health, Metabolics, and International Business at Abbott India Limited
Giri is currently the President (India Business & Emerging Markets) of Amneal Pharmaceuticals
A seasoned professional, he will lead the strategy and business operations of Cadila’s branded prescriptions pharma business
PPH is associated with almost 20 per cent of maternal mortality in India
Vikas Lifecare has already paid Rs. 25 million to the Advik bankers till date and the remaining amount shall also be paid within July 2021, making Advik a debt free company
Subscribe To Our Newsletter & Stay Updated
